Bill
Bill > HR1725
US HR1725
US HR1725National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
summary
Introduced
03/26/2015
03/26/2015
In Committee
07/29/2015
07/29/2015
Crossed Over
09/09/2015
09/09/2015
Passed
Dead
01/03/2017
01/03/2017
Introduced Session
114th Congress
Bill Summary
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 (Sec. 2) Amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a purpose of state-administered controlled substance monitoring systems ensuring access to prescription history information for the investigative purposes of appropriate law enforcement, regulatory, and state professional licensing authorities. (Sec. 3) Amends the Public Health Service Act to revise and reauthorize through FY2020 the controlled substance monitoring program, including to: allow grants to be used to maintain and operate existing state controlled substance monitoring programs, require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees, require a state to provide HHS with aggregate data and other information to enable HHS to evaluate the success of the state's program, and expand the program to include any commonwealth or territory of the United States. Allows the Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes to make that information available to other entities for research purposes. Requires a state receiving a grant to: (1) facilitate prescriber and dispenser use of the state's controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system both to them and society.
AI Summary
This bill, the National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015, aims to strengthen and extend federal support for state-run controlled substance monitoring programs, which track the dispensing of prescription drugs to help prevent abuse and addiction. It clarifies that these systems should provide access to prescription history for law enforcement and regulatory bodies for investigative purposes, in addition to their existing role in helping healthcare providers identify patients at risk of addiction. The bill reauthorizes funding for these programs through fiscal year 2020, allowing grants to be used for maintaining existing state programs and requiring the Department of Health and Human Services (HHS) to redistribute any returned funds among other grantees. States receiving grants must provide data to HHS for program evaluation and expand their programs to include U.S. commonwealths and territories. Furthermore, the bill allows non-identifiable data from these monitoring systems, when shared for research purposes with entities like the Drug Enforcement Administration (DEA) or state health departments, to be further shared with other research entities. Finally, states receiving grants are required to actively promote the use of their monitoring systems by prescribers and dispensers, educating them on the system's benefits to both their practice and society.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (14)
Ed Whitfield (R)*,
Gus Bilirakis (R),
Larry Bucshon (R),
Michael Burgess (R),
Katherine Clark (D),
Barbara Comstock (R),
Bill Johnson (R),
Bill Keating (D),
Joseph Kennedy (D),
Ann Kuster (D),
Doris Matsui (D),
Jim McGovern (D),
Seth Moulton (D),
Frank Pallone (D),
Last Action
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 09/09/2015)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...